Breaking: Lykos Therapeutics Moved to Patent MDMA In Late 2022, Filing Reveals
Starting in December 2022, Lykos Therapeutics filed a suite of MDMA-related provisional patent applications, according to a Patent Cooperation Treaty application published today. The move signals a…